An interview with Kitty van Weezenbeek, Director of Surveillance, Prevention and Control of AMR for the World Health Organistion (WHO) AMR division.
Bintrafusp alfa by Merck for Head And Neck Cancer Squamous Cell Carcinoma: Likelihood of Approval – Pharmaceutical Technology
GlobalData tracks drug-specific phase transition and likelihood of approval scores, in addition to indication benchmarks based off 18 years of historical drug development data. Attributes